Final IOP outcome | Visual acuity | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Complete success | Partial success | Failure | Improvement | Unchanged | Worsening | |||||||
n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | n (%) | IC (99.61%) | |
Herpes | 6 (67) | 22–100% | 1 (11) | 0–41% | 2 (22) | 0–62% | 6 (67) | 22–100% | 1 (11) | 0–41% | 2 (22) | 0–62% |
Fuchs’ heterochromic cyclitis | 1 (20) | 0–72% | 0 (0) | – | 4 (80) | 28–100% | 3 (60) | 0–100% | 1 (20) | 0–72% | 1 (20) | 0–72% |
Ankylosing spondylitis | 2 (50) | 0–100% | 0 (0) | – | 2 (50) | 0–100% | 1 (25) | 0–87% | 1 (25) | 0–87% | 2 (50) | 0–100% |
Anterior idiophatic | 0 (0) | – | 0 (0) | – | 3 (100) | – | 2 (67) | 0–100% | 0 (0) | – | 1 (33) | 0–100% |
Tuberculosis | 0 (0) | – | 2 (100) | – | 0 (0) | – | 2 (100) | – | 0 (0) | – | 0 (0) | – |
Behçet disease | 1 (100) | – | 0 (0) | – | 0 (0) | – | 0 (0) | – | 0 (0) | – | 1 (100) | – |
Pars planitis | 1 (100) | – | 0 (0) | – | 0 (0) | – | 0 (0) | – | 1 (100) | – | 0 (0) | – |
Posner–Schlossman | 1 (100) | – | 0 (0) | – | 0 (0) | – | 0 (0) | – | 1 (100) | – | 0 (0) | – |
Sarcoidosis | 1 (100) | – | 0 (0) | – | 0 (0) | – | 1 (100) | – | 0 (0) | – | 0 (0) | – |